Phathom Pharmaceuticals, Inc. Common Stock PHAT
$5.94
+3.48%
at last close
Analyst Consensus
- Consensus Rating
- Buy (4 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $18.80
- Implied Upside
- +216.5%
- Price Target Range
- $10.00 – $26.00
- Analysts (12 mo)
- 5
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-09 | Leerink PartnersDaniel Clark |
Initiates coverage on | Market perform | $10 |
| 2026-08-17 | BarclaysGlen Santangelo |
Maintains | Overweight | $18 → $14 |
| 2026-07-31 | GuggenheimYatin Suneja |
Maintains | Buy | $25 → $22 |
| 2026-07-31 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $26 |
| 2026-07-30 | NeedhamJoseph Stringer |
Maintains | Buy | $28 → $22 |
| 2026-06-17 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $26 |
| 2026-03-27 | BarclaysGlen Santangelo |
Upgrades | Equal-weight → Overweight | $16 → $18 |
| 2026-02-27 | GuggenheimYatin Suneja |
Maintains | Buy | $20 → $25 |
| 2025-12-09 | BarclaysGlen Santangelo |
Initiates coverage on | Equal-weight | $16 |
| 2025-10-31 | HC Wainwright & Co.Matthew Caufield |
Maintains | Buy | $20 → $26 |
| 2025-06-09 | Craig-HallumChase Knickerbocker |
Maintains | Buy | $12 → $17 |
| 2025-06-09 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $20 |
| 2025-06-06 | NeedhamJoseph Stringer |
Maintains | Buy | $28 |
| 2025-05-02 | Goldman SachsPaul Choi |
Maintains | Neutral | $10 → $5 |
| 2025-05-02 | GuggenheimYatin Suneja |
Maintains | Buy | $18 → $12 |
| 2025-05-02 | HC Wainwright & Co.Matthew Caufield |
Maintains | Buy | $28 → $20 |
| 2025-04-21 | NeedhamJoseph Stringer |
Reiterates | Buy | $28 |
| 2025-04-17 | Goldman SachsPaul Choi |
Maintains | Neutral | $12 → $10 |
| 2025-04-09 | NeedhamJoseph Stringer |
Reiterates | Buy | $28 |
| 2025-04-02 | GuggenheimYatin Suneja |
Reiterates | Buy | — |
| 2025-04-02 | NeedhamJoseph Stringer |
Reiterates | Buy | $28 |
| 2025-03-10 | Goldman SachsPaul Choi |
Maintains | Neutral | $18 → $12 |
| 2025-03-07 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $28 |
| 2025-03-06 | NeedhamJoseph Stringer |
Reiterates | Buy | $28 |
| 2025-01-10 | NeedhamJoseph Stringer |
Reiterates | Buy | $28 |
| 2024-12-12 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $28 |
| 2024-12-11 | NeedhamJoseph Stringer |
Reiterates | Buy | $28 |
| 2024-09-13 | NeedhamJoseph Stringer |
Reiterates | Buy | $26 |
| 2024-09-06 | NeedhamJoseph Stringer |
Reiterates | Buy | $26 |
| 2024-08-30 | NeedhamJoseph Stringer |
Reiterates | Buy | $26 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $5.94
- Market Cap
- $464.37 million
- 52-Week Range
- $5.01 – $18.31
- Average Volume
- 1.47 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.